Skip to main content
. 2024 May 24;24:181. doi: 10.1186/s12876-024-03241-8

Table 2.

Factors associated with delay in receiving treatment*

Characteristics Not treated within 30 days,
N = 561
Treated within 30 days,
N = 501
OR1 95% CI1 p-value
Age at diagnosis, median (IQR) 68 (62, 78) 69 (60, 74) 1.03 0.99, 1.06 0.12
Gender
Female 24 (43%) 17 (34%)
Male 32 (57%) 33 (66%) 0.69 0.31, 1.51 0.4
WBC at presentation, median (IQR) 7.9 (6.6, 10.1) 6.6 (5.2, 8.2) 1.21 1.06, 1.40 0.009
Bilirubin level at presentation, median (IQR) 7 (1, 12) 2 (1, 9) 1.04 0.99, 1.10 0.14
Presented with cholangitis
No 49 (88%) 49 (98%)
Yes 7 (13%) 1 (2.0%)
Presented with jaundice
No 24 (43%) 37 (74%)
Yes 32 (57%) 13 (26%) 3.79 1.69, 8.88 0.002
Presented or drained for cholangitis* 7.26 1.87, 48.1 0.012
0 43 (77%) 48 (96%)
1 13 (23%) 2 (4.0%)
STENT status
No prior STENT 14 (25%) 19 (38%)
Prior STENT/not draining liver 19 (34%) 7 (14%) 3.68 1.26, 11.7 0.021
Prior STENT/draining liver 23 (41%) 24 (48%) 1.30 0.53, 3.22 0.6

* Treatment was defined as receiving surgery, chemotherapy, radiation, PV embolization within 30 days of presentation

* 1 Univariate logistic regression model estimating the odds ratio of treatment delayed ; OR = Odds ratio CI = confidence interval